D.ZhengH
Provide your complete medical history, particularly if you are pregnant or planning to become pregnant, are breastfeeding or planning to breastfeed, have any planned surgeries or procedures, or if you have a history of diabetes, thyroid cancer, pancreatitis, ileus, severe gastroparesis, kidney disease, gallstones, or diabetic eye disease
Taking shortcuts, such as attempting to take semaglutide and tirzepatide together can potentially derail your treatment and lead to life-threatening consequences
Its the subject of ongoing studies
Titration schedule of Rybelsus is as follows: Formulation R1 (3 mg, 7 mg, 14 mg) Weeks 14 (Days 130): 3 mg once daily (This is the starting dose that may not be effective for glycemic control) Weeks 58 (Days 3160): 7 mg once daily Weeks 9 and onwards (Day 61+): Maintain 7 mg once daily if adequate control is achieved Increase to 14 mg once daily if additional glycemic control needed Formulation R2 (1.5 mg, 4 mg, 9 mg) Week 14 (Days 130): 1.5 mg once daily Week 58 (Days 3160): 4 mg once daily Week 9 onward (Day 61+): Maintain 4 mg once daily if adequate control is achieved or, Increase to 9 mg once daily if additional glycemic control is needed Why a conversion chart matters Liraglutide, semaglutide, and dulaglutide are GLP-1 agonists, but they have different active ingredients, indications, efficacy, and potencies